Prevention and treatment of primary (menopausal, senile) and secondary osteoporosis (Hyper-(para -) thyroidism, steroid, heparin, idiopathic); prevention and treatment of calcium and/or vitamin D3 deficiency (pregnancy, lactation, period of increased growth, to accelerate the consolidation of fractures)
The main active ingredients of one tablet are: calcium carbonate – 1111 mg, cholecalciferol (vitamin D3) – 3.75 mg (150 IU), magnesium oxide – 100 mg, zinc oxide – 3.11 mg.
Also, the composition of the drug includes secondary substances vegetable stearin, sorbitol, peppermint essential oil, silicon dioxide, acesulfame, sucralose, aspartame. The cardboard box contains 2 blisters of 15 chewable tablets.
It is produced in the form of chewable tablets.
The drug Osteovis is an effective agent that supports the process of calcium metabolism, contributes to the correction of cartilage and bone tissue and strengthens bones. Osteovis compensates for the lack of calcium, magnesium, vitamin D3 and zinc, and is also used for prophylaxis. Calcium, which is part of the drug, takes part in the formation and maintenance of the structure of bone tissue, ensures its strength. Magnesium activates the absorption of calcium in the body, makes it possible to preserve bone structure, also prevents certain forms of arthritis and the formation of kidney stones. Vitamin D3 controls calcium-phosphorus metabolism, increases the absorption of phosphates and calcium in the intestines, helps to strengthen bones, the formation of teeth in children. Also, vitamin D3 is necessary for the normal functioning of the parathyroid glands. Zinc contributes to the normal development of bone tissue, activates cell growth and division, tissue regeneration. This element is very important during the period of intensive growth of children, after increased stress and fractures.
Indications for use
Osteovis is used for the complex treatment and prevention of osteoporosis (senile, menopausal, steroid, idiopathic); with an increased need for calcium during pregnancy and lactation; also Osteovis is used for therapeutic and prophylactic purposes for rickets, during the period of intensive growth in adolescents and children; with periodontal disease, idiopathic periodontal diseases, periodontitis; for diseases that are accompanied by hypocalcemia.
Contraindicated in patients with sensitive susceptibility to the components of the drug, with phenylketonuria, as well as in children under 6 years of age.
It is used in pediatrics for children from 6 years old.
Application during pregnancy and lactation
Before taking the drug, women in position and breastfeeding mothers should consult a doctor.
Method of administration and dosage
Osteovis is used and prescribed for children aged 6 to 12 years, 1 tablet per day. For adults, as well as for children over 12 years of age, the recommended dose is 1-2 tablets per day. Women in position, nursing mothers and the elderly are allowed to take up to 3-4 tablets per day. Take the tablets immediately after meals, chew and drink water or juice.
There were no precedents of overdose with tablets.
The drug is well tolerated by patients and even with long-term use of side effects were not observed.
Storage conditions and periods
Store Osteovis tablets in a dry and cool place, and the drug should not be available to children. The expiration date is indicated on the packaging.